igf-1 lr3 gh gut prevention The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations Insulin Like Growth Factor 1

Recent studies demonstrated that KD improved motor function and protected dopaminergic neurons in MPTP-induced mouse model of PD [68]

J Med ChemRational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease

For weight loss and metabolism Semaglutide (GLP-1 agonist) - #1 for menopausal weight: Why it's best: Directly addresses insulin resistance common after 40 Reduces appetite dramatically 15-20% body weight loss typical Works when diet/exercise alone fail FDA-approved for weight loss Dosing for women 40+: Start: 0.25mg weekly Titrate slowly to 1-2.4mg over 16-20 weeks Weekly injection subcutaneous 3-6+ months for best results Timeline: Month 1: Appetite reduction begins Month 2-3: 10-15 lbs lost Month 4-6: 20-30 lbs lost (if needed) Maintain: Lower dose ongoing Use our semaglutide dosage calculator and see semaglutide vs tirzepatide comparison

Protocol structure: 3-month progressive dose escalation, 5 days on/2 days off, before bed

[ 266 ] The oxidation of polyunsaturated fatty acids (PUFAs) functions centrally in ferroptosis